8 authorised products containing Ertugliflozin l-pyroglutamic acid, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Segluromet 2.5 mg/1 000 mg film-coated tablets EU/1/18/1265/008-014 |
Ertugliflozin l-pyroglutamic acid, Metformin Hydrochloride | Merck Sharp & Dohme BV | — |
| Segluromet 2.5 mg/850 mg film-coated tablets EU/1/18/1265/001-007 |
Metformin Hydrochloride, Ertugliflozin l-pyroglutamic acid | Merck Sharp & Dohme BV | — |
| Segluromet 7.5 mg/1 000 mg film-coated tablets EU/1/18/1265/022-028 |
Ertugliflozin l-pyroglutamic acid, Metformin Hydrochloride | Merck Sharp & Dohme BV | — |
| Segluromet 7.5 mg/850 mg film-coated tablets EU/1/18/1265/015-021 |
Ertugliflozin l-pyroglutamic acid, Metformin Hydrochloride | Merck Sharp & Dohme BV | — |
| Steglatro 15 mg film-coated tablets EU/1/18/1267/007-012 |
Ertugliflozin l-pyroglutamic acid | Merck Sharp & Dohme BV | — |
| Steglatro 5 mg film-coated tablets EU/1/18/1267/001-006 |
Ertugliflozin l-pyroglutamic acid | Merck Sharp & Dohme BV | — |
| Steglujan 15 mg/100 mg film-coated tablets EU/1/18/1266/007-012 |
Ertugliflozin l-pyroglutamic acid, Sitagliptin phosphate monohydrate | Merck Sharp & Dohme BV | — |
| Steglujan 5 mg/100 mg film-coated tablets EU/1/18/1266/001-006 |
Ertugliflozin l-pyroglutamic acid, Sitagliptin phosphate monohydrate | Merck Sharp & Dohme BV | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.